The tariff classification of Investigational New Drug VX-770 (N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide) in bulk and in dosage forms, from Portugal and the United Kingdom
Reasoning
The tariff classification of Investigational New Drug VX-770 (N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide) in bulk and in dosage forms, from Portugal and the United Kingdom
Cite this ruling
CBP Ruling N013396 (2933492600): The tariff classification of Investigational New Drug VX-770 (N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide) in bulk and in dosage forms, from Portugal and the United Kingdom
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293349
The tariff classification of Quinapril HCL (CAS-82586-55-8) in bulk, from India
The tariff classification 2,4-Dihydroxyquinoline (CAS 86-95-3) from Korea
The tariff classification of Butorphanol Tartrate (CAS- 58786-99-5) imported in bulk form, from India
The tariff classification of Cisatracurium Besylate (CAS# 96946-42-8) in bulk form, from Italy
The tariff classification of 2-Methoxycarbonyl-6-oxodecahydroisoquinoline-3-carboxylic R-(+) alphamethylbenzylamine salt, CAS no. unknown, imported in bulk form, from England